Japan BioBridge PMDA Study Completion

Terumo Corporation announced that the first clinical trial conducted in Japan for evaluation the BioBridge® Collagen Matrix in the surgical treatment of lymphedema has reached its endpoint. Terumo is managing and funding clinical studies in Japan which are being used for regulatory (PMDA) approval.

The PMDA study evaluated BioBridge in a procedure for women that have acquired breast cancer-related lymphedema. Enrollment in this single-arm study was completed across four clinical sites (Chiba Univ. Hospital, Yokohama City Univ. Hospital, Okayama Univ. Hospital, and Saitama Medical Center) in January 2024, with a total of 21 patients enrolled.

This clinical study final report is being prepared for PMDA submission.

BioBridge Symposium held at 30th World Congress of the International Society of Lymphology (ISL)

BioBridge Symposium held at 30th World Congress of the International Society of Lymphology (ISL)

Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology (ISL), which was held 15-19 October 2025 in Antalya, Turkey. As part of this session, Dr. Corrado Campisi, incoming President of ISL, presented his prospective randomized clinical study (n=34) using BioBridge with advanced microsurgerical procedures.

This was the second time that ISL hosted a BioBridge-focused session during their bi-annual congress meeting, with the previous session held in Genoa, Italy in September, 2023.

read more
Good Moonwha Hospital completes 100th BioBridge surgical case milestone.

Good Moonwha Hospital completes 100th BioBridge surgical case milestone.

Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology (ISL), which was held 15-19 October 2025 in Antalya, Turkey. As part of this session, Dr. Corrado Campisi, incoming President of ISL, presented his prospective randomized clinical study (n=34) using BioBridge with advanced microsurgerical procedures.

This was the second time that ISL hosted a BioBridge-focused session during their bi-annual congress meeting, with the previous session held in Genoa, Italy in September, 2023.

read more
Fibralign Sponsors International Research Seminar

Fibralign Sponsors International Research Seminar

  Fibralign hosted the Lymphedema Summit on January 23, 2022, an international research seminar focused on “Advancements in Lymphedema Surgical Treatment.” This special event featured a gathering of the leading surgeons and researchers in this field and took...

read more